Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Creative Medical Technology Holdings ( (CELZ) ).
On December 26, 2025, Creative Medical Technology Holdings held a special meeting of stockholders to vote on a proposal to approve the full exercise of warrants to purchase 2,790,340 shares of its common stock, originally issued on October 29, 2025. Shareholders representing 36.4% of outstanding shares formed a quorum, and the proposal was approved with 618,178 votes in favor, 183,985 against, and 235,381 abstentions, with 220,500 votes by warrant holders counted as abstentions under Nasdaq rules, paving the way for potential warrant exercises that could increase the company’s common share count and capital base.
The most recent analyst rating on (CELZ) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Creative Medical Technology Holdings stock, see the CELZ Stock Forecast page.
More about Creative Medical Technology Holdings
Average Trading Volume: 110,307
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.85M
Learn more about CELZ stock on TipRanks’ Stock Analysis page.